Clinical trial
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due…
NCT00190814 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00190814 |
|---|---|
| Title | Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. |
| Official title | Efficacy and Safety of Duloxetine Compared With Placebo in Women With Symptoms of Mixed Urinary Incontinence. |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Stress |
| Intervention type | Drug |
| Interventions | duloxetine, placebo |
| Enrollment | 600 |
| Start date | Sep 1, 2003 |
| Completion | May 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | Canada, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: